Growth Hormone Treatment in Short Children Born Small for Date (Genotonorm)
Growth Hormone Treatment in Short Children Born Small for Date (Genotonorm)
The primary objective is to evaluate, if Genotonorm (Genotropin) increases linear growth in short children born SGA. Safety of the drug is a main objective as well. The growth promoting effect of two different dosages is compared. The effect of long-term treatment on final height is evaluated (according to several amendments)
Inclusion Criteria:
Exclusion Criteria: